DE69636790D1 - Interferon-beta gegen knochenerkrankungen - Google Patents

Interferon-beta gegen knochenerkrankungen

Info

Publication number
DE69636790D1
DE69636790D1 DE69636790T DE69636790T DE69636790D1 DE 69636790 D1 DE69636790 D1 DE 69636790D1 DE 69636790 T DE69636790 T DE 69636790T DE 69636790 T DE69636790 T DE 69636790T DE 69636790 D1 DE69636790 D1 DE 69636790D1
Authority
DE
Germany
Prior art keywords
interferon
bone diseases
against bone
beta against
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69636790T
Other languages
English (en)
Other versions
DE69636790T2 (de
Inventor
Nobutaka Ida
Tomohiko Suzuki
Emi Kumagai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of DE69636790D1 publication Critical patent/DE69636790D1/de
Application granted granted Critical
Publication of DE69636790T2 publication Critical patent/DE69636790T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69636790T 1995-07-25 1996-07-25 Interferon-beta gegen knochenerkrankungen Expired - Fee Related DE69636790T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18897295 1995-07-25
JP18897295 1995-07-25
PCT/JP1996/002099 WO1997004799A1 (fr) 1995-07-25 1996-07-25 Remede contre les maladies osseuses

Publications (2)

Publication Number Publication Date
DE69636790D1 true DE69636790D1 (de) 2007-02-08
DE69636790T2 DE69636790T2 (de) 2007-10-11

Family

ID=16233155

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69636790T Expired - Fee Related DE69636790T2 (de) 1995-07-25 1996-07-25 Interferon-beta gegen knochenerkrankungen

Country Status (6)

Country Link
US (1) US20050180954A1 (de)
EP (3) EP0783891B1 (de)
JP (1) JP4066460B2 (de)
CA (1) CA2200879A1 (de)
DE (1) DE69636790T2 (de)
WO (1) WO1997004799A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9610281D0 (en) * 1996-05-16 1996-07-24 Ralston Stuart H Diagnostic method and apparatus
FR2791894B1 (fr) * 1999-04-09 2001-07-13 Inst Nat Sante Rech Med Utilisation d'interferon beta dans le traitement de la tumeur d'ewing
AU2001288095A1 (en) * 2000-09-21 2002-04-02 Center For Advanced Science And Technology Incubation, Ltd. Method of regulating osteoclast formation
JPWO2002024228A1 (ja) * 2000-09-21 2004-01-29 株式会社先端科学技術インキュベーションセンター 破骨細胞形成を制御する方法
RU2669051C1 (ru) * 2017-07-11 2018-10-05 Федеральное государственное бюджетное научное учреждение "Иркутский научный центр хирургии и травматологии" (ИНЦХТ) Способ лечения несросшегося перелома костей конечности
CN117138038A (zh) * 2023-09-21 2023-12-01 北京大学 一种预防、治疗或缓解椎体后纵韧带骨化症的药物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5758630A (en) * 1980-09-25 1982-04-08 Kayaku:Kk Interferon inducer
DE3423234A1 (de) * 1984-06-23 1986-02-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Synergistische mischungen von interferonen und tumor-nekrose-faktor
DE3519361A1 (de) * 1985-05-30 1986-12-04 Boehringer Ingelheim International GmbH, 6507 Ingelheim (gamma)-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen
US5024833A (en) * 1988-03-10 1991-06-18 Industrial Farmaceutica Serono Spa Combined interferon/antiestrogen therapy for treatment of breast cancer
US4851219A (en) * 1986-11-18 1989-07-25 Genentech, Inc. Method for the treatment of chronic myelogenous leukemia
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5268169A (en) * 1989-02-02 1993-12-07 Roussel Uclaf Treatment method of ovarian cancer using interferon gamma
IL89662A (en) * 1989-03-19 1997-11-20 Interpharm Lab Ltd Kiryat Weiz Pharmaceutical compositions comprising interferon-beta
JPH0477431A (ja) * 1990-07-19 1992-03-11 Kanebo Ltd インターフェロン誘起剤
JPH07215893A (ja) * 1994-02-04 1995-08-15 Hiroyo Morii 骨量増加剤
US5417982A (en) * 1994-02-17 1995-05-23 Modi; Pankaj Controlled release of drugs or hormones in biodegradable polymer microspheres
US5565558A (en) * 1994-12-30 1996-10-15 Mccully; Kilmer S. Thioretinaco ozonide and enhanced biological activity of thioretinaco ozonide in combination with interferon

Also Published As

Publication number Publication date
EP1759708A1 (de) 2007-03-07
EP0783891A1 (de) 1997-07-16
US20050180954A1 (en) 2005-08-18
EP1416282A2 (de) 2004-05-06
WO1997004799A1 (fr) 1997-02-13
EP1416282A3 (de) 2004-06-23
JP4066460B2 (ja) 2008-03-26
CA2200879A1 (en) 1997-02-13
EP0783891B1 (de) 2006-12-27
EP0783891A4 (de) 2002-04-17
DE69636790T2 (de) 2007-10-11

Similar Documents

Publication Publication Date Title
DE69629360D1 (de) Chirurgische prothese
DE69627026D1 (de) Osteosynthesevorrichtung
FI971279A (fi) Lääkkeitä
DE69736228D1 (de) Medizinische stents
IS4662A (is) Innúðatæki
DE69606550T2 (de) Medizinischen verbindungsanordnung
DE59509539D1 (de) Zwischenwirbel-implantat
FR2729291B1 (fr) Implant rachidien
DE59507573D1 (de) Implantat
IS4698A (is) Innúðatæki
DE9403231U1 (de) Chirurgisches Implantat
DE9402695U1 (de) Implantat
DK0830166T3 (da) Inhalationsapparat
DE69636790D1 (de) Interferon-beta gegen knochenerkrankungen
ATE397073T1 (de) Menschliche dnase i varianten
DE59602924D1 (de) Knochenraspel
ITMI950222A0 (it) Tessuto
KR960030492U (ko) 의료용 멸균기
DE69621586D1 (de) Osteosynthesehilfsmittel
DE29503674U1 (de) Zerlegbarer Patienten-Lothublifter in Leichtausführung
KR960033544U (ko) 환자용 배뇨기
DE29501471U1 (de) Orthopädische Einlage
DE9406967U1 (de) Implantatanordnung
KR970008083U (ko) 티슈통의 장식 케이스
FI1449U1 (fi) Anatomisk omformbar kudde

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee